Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Rhabdomyosarcoma, Alveolar × Crizotinib × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Plasma cell 1 Lymphoid 1

Conditions

Lymphoma, Large-Cell, Anaplastic 6 Multiple Myeloma 4 Lymphoma 4 Neuroblastoma 3 Hematologic Neoplasms 2 Granuloma, Plasma Cell 2 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Rhabdomyosarcoma, Alveolar 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Crizotinib 1 BAY 1895344 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01524926 2023-12-11

CREATE

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed

LymphoidPlasma cellSarcoma

Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic, Sarcoma, Clear Cell, Rhabdomyosarcoma, Alveolar, Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon ⚡